Contact Us

DESTINATION NEWS

2024 Marks Breakout Year for China's ETF Market with Unprecedented Growth

Jan 13, 2025

GUANGZHOU,China,Jan. 10,2025--China\'s ETF market demonstrated exceptional performance in 2024,with notable returns and substantial growth in assets under management. According to Wind,the average re

WuXi AppTec Joins the Pharmaceutical Supply Chain Initiative (PSCI)

Jan 13, 2025

SHANGHAI,Jan. 13,2025-- WuXi AppTec,a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences industries,announ

Skyee Receives In-Principle Approval (IPA) for Major Payment Institution License (MPI) from the Monetary Authority of Singapore (MAS)

Jan 13, 2025

SINGAPORE,Jan. 13,2025-- Skyee Pte. Ltd. ("Skyee") is excited to announce that it has been granted In-Principle Approval (IPA) for the Major Payment Institution (MPI) license from the Moneta

Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery

Jan 13, 2025

Funding from leading investors to accelerate R&D and international expansion to make robotic surgery solutions accessible to more

Duke-NUS marks 20 years with transformative S$30m in philanthropic gifts and pledges to boost next-gen medical breakthroughs

Jan 13, 2025

The legacy of Duke-NUS\' founding donor,the Estate of Khoo Teck Puat,continues with a transformative S$5.5 million gift towards research.

SN BioScience Propels SNB-101 to Phase 2 with IND Clearance from FDA

Jan 11, 2025

SEOUL,South Korea,Jan. 10,2025-- SNBioScience today announced that its lead asset SNB-101 has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for a

1 ... 143 144 145 146 147 148 149 ... 373